Navigation Links
Siemens Extends Tender Offer for Acquisition of Dade Behring
Date:9/5/2007

NEW YORK, Sept. 5 /PRNewswire-FirstCall/ -- Belfast Merger Co., a wholly owned subsidiary of Siemens Corporation, announced today that it has extended the expiration date for its cash tender offer for all outstanding shares of common stock of Dade Behring Holdings, Inc. (Nasdaq: DADE). The tender offer has been extended to 12:00 Midnight, New York City time, on Wednesday, September 26, 2007. The tender offer is being made pursuant to an Agreement and Plan of Merger, dated as of July 25, 2007, by and among Siemens, its subsidiary, Belfast Merger Co., and Dade Behring. Completion of the tender offer is conditioned on, among other things, receipt of regulatory approvals.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

As of 4:00 p.m., New York City time, on Wednesday, September 5, 2007, an aggregate of 39,128,122 shares of common stock of Dade Behring had been validly tendered and not withdrawn, representing 48.82 percent of the outstanding common stock of Dade Behring.

About Siemens

Siemens AG (NYSE: SI) (Berlin and Munich) is a global powerhouse in electrical engineering and electronics. The company has around 475,000 employees (incl. discontinued operations) working to develop and manufacture products, design and install complex systems and projects, and tailor a wide range of services for individual requirements. Siemens provides innovative technologies and comprehensive know-how to benefit customers in over 190 countries. Founded more than 160 years ago, the company focuses on the areas of Information and Communications, Automation and Control, Power, Transportation, Medical, and Lighting. In fiscal 2006 (ended September 30), Siemens had sales of euro87.3 billion and net income of euro3.033 billion, according to U.S. GAAP. Further information is available on the Internet at: http://www.siemens.com.

About Dade Behring

With 2006 revenue of more than US$1.7 billion, Dade Behring offers a wide range of products, systems and services designed to meet the day-to-day needs of clinical laboratories, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the Internet at http://www.dadebehring.com.

This announcement is for informational purposes only and does not constitute an offer to purchase nor a solicitation of an offer to sell any securities. The Tender Offer Statement on Schedule TO, the Offer to Purchase and related materials filed by Siemens with the Securities and Exchange Commission ("SEC") contain important information and should be read carefully before any decision is made with respect to the tender offer. These materials are available at no charge on the SEC's web site (http://www.sec.gov) and requests for additional copies of such materials may be directed to Georgeson Inc., the Information Agent for the tender offer. The Information Agent can be reached at 17 State Street, 10th Floor, New York, New York 10004. Banks and brokers can call (212) 440-9800 and all others can call toll free at (888) 605-7608.


'/>"/>
SOURCE Siemens AG
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. India extends National TB Control Program
2. Irish Medicines Board Extends Paracetamol Recall To All Batches
3. Treatment Extends Survival in Mouse Model of Spinal Muscular Atrophy
4. Caloric Restriction in Non-obese People Extends Life Span
5. Vitamin Extends Life in Yeast, Dartmouth Medical School Researchers Find
6. Nexavar Significantly Extends Survival of Liver Cancer Patients
7. Ranbaxy Labs Extends Roots in South Africa
8. Vitamin Extends Life in Yeast, Dartmouth Medical School Researchers Find
9. Singapore Extends Smoking Ban to Pubs, Nightclubs
10. CCEA Extends National TB Control Project for Five Years
11. FDA Extends GRAS Approval Listex to All Food Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... IT operations analytics and application performance monitoring (APM) solutions, has expanded its ... services providers. , According to Peter Ohrenberger, sales director at Nastel, “We’ve ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended hospital ... adjustable beds used in such facilities are specially designed to accommodate patients with a ... , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, ...
(Date:7/20/2017)... ATLANTA, Ga. (PRWEB) , ... July 20, 2017 , ... ... and equal access to medicine for everyone affected by diabetes, is teaming up with ... the five-day global event kicks off on July 24th. , “Team Type 1’s ...
(Date:7/20/2017)... MD (PRWEB) , ... July 20, 2017 , ... ... company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary ... million. , Proceeds will be used to complete regulatory submissions and fund final ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
(Date:7/10/2017)... -- The Institute for In Vitro Sciences (IIVS), a ... a VITROCELL® inhalation exposure system thanks to a generous ... which is designed to replace animals in inhalation testing, ... airborne test materials in an environment that mimics the ... testing combustible tobacco products, as well as next generation ...
(Date:7/10/2017)... -- The tenth annual BioPharm America™ will take ... the Sheraton Boston Hotel, September 26–27. The event will ... makers and innovative biotech startup companies. The event is ... impactful days. BioPharm America is now part of Biotech ... with 4,500+ life science industry influencers participating in 8+ ...
Breaking Medicine Technology: